Family Medicine
Case series: Vaccine-induced thrombocytopenia with severe headache may precede cerebral venous sinus thrombosis by several days – patients with severe headache 5 to 20 days after adenovirus vector vaccination against Covid-19 should undergo immediate testing for thrombocytopenia and d-dimer levels and, if available, testing for anti–PF4–heparin IgG antibodies.
16 Sep, 2021 | 10:14h | UTCVaccine-Induced Thrombocytopenia with Severe Headache – New England Journal of Medicine
Commentary on Twitter
Experience with 11 patients suggests that elements of VITT (severe headache, elevated d-dimer levels, and positivity for anti-PF4 antibodies) after ChAdOx1 nCoV-19 vaccination may precede VITT. #Covid19Vaccines #COVID19 #SARSCoV2 #IDTwitter https://t.co/mzBgjJIE6l pic.twitter.com/wGqb1gKFXk
— NEJM (@NEJM) September 15, 2021
COVID vaccine effects wane over time but still prevent death and severe illness.
16 Sep, 2021 | 10:10h | UTCCOVID vaccine effects wane over time but still prevent death and severe illness – The Conversation
Related:
Perspective | What we actually know about waning immunity.
Another study shows Pfizer mRNA vaccine immunity is reduced over time.
Studies: COVID vaccine protection waning against infection but not hospitalization.
Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.
An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.
16 Sep, 2021 | 10:13h | UTCProtection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine
Perspective | Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain.
16 Sep, 2021 | 10:06h | UTCSchools have begun mass testing for COVID-19. But hurdles and uncertainties remain – Science
State of the Art Review: Eosinophils in Health and Disease.
16 Sep, 2021 | 09:59h | UTCEosinophils in Health and Disease: A State-of-the-Art Review – Mayo Clinic Proceedings
Review: Is there an optimal antiplatelet strategy after gastrointestinal bleeding in patients with coronary artery disease?
16 Sep, 2021 | 09:57h | UTC
State of the Art Review: Screening and prevention of colorectal cancer.
16 Sep, 2021 | 10:01h | UTCScreening and prevention of colorectal cancer – The BMJ (free for a limited period)
Related:
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Systematic Review: Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose?
16 Sep, 2021 | 09:55h | UTCOriginal Study: Electronic cigarettes for smoking cessation – Cochrane Library
Commentary on Twitter
Can #ecigarettes help you #quitsmoking? Latest Evidence is in! https://t.co/04UN47MoOm pic.twitter.com/pDugyzeEmh
— CochraneTAG (@CochraneTAG) September 14, 2021
A guide to the treatment of cellulitis and other soft-tissue infections.
16 Sep, 2021 | 09:47h | UTCA guide to the Tx of cellulitis and other soft-tissue infections – Journal of Family Practice
Cluster RCT: Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission.
15 Sep, 2021 | 10:01h | UTCInvited commentary: Daily antigen testing to reduce disruption when schools return – The Lancet
Review | Prevention of host-to-host transmission by SARS-CoV-2 vaccines.
15 Sep, 2021 | 09:16h | UTCPrevention of host-to-host transmission by SARS-CoV-2 vaccines – The Lancet Infectious Diseases
Related:
Study ties COVID vaccines to lower transmission rates.
Covid-19 vaccination prevents transmission from vaccinated to unvaccinated household members.
Ivermectin: Cochrane’s most talked about review so far, ever. Why?
15 Sep, 2021 | 09:07h | UTCIvermectin: Cochrane’s most talked about review so far, ever. Why? – Cochrane Library
Original review: Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.
Commentary on Twitter
Ivermectin: Cochrane’s most talked about review so far, ever. Why?https://t.co/KmOLR9qHrF#ivermectin #evidencesynthesis #systematicreviews #COVID19 #Cochrane #publichealth #globalhealth #medicine pic.twitter.com/twLyqzSrcF
— Cochrane US Network (@Cochrane_US) September 14, 2021
Supplement: FIGO Working Group for Preterm Birth – Good Practice Recommendations.
15 Sep, 2021 | 08:56h | UTCEditorial: FIGO good practice recommendations for reducing preterm birth and improving child outcomes
FIGO good practice recommendations on modifiable causes of iatrogenic preterm birth
FIGO good practice recommendations on progestogens for prevention of preterm delivery
FIGO good practice recommendations on cervical cerclage for prevention of preterm birth
FIGO good practice recommendations on delayed umbilical cord clamping
CDC report finds unvaccinated people are 11 times more likely to die of COVID-19.
15 Sep, 2021 | 09:09h | UTCUnvaccinated People Are 11 Times More Likely To Die Of COVID-19, New Research Finds – NPR
Commentary on Twitter
New @CDCMMWR shows fully vaccinated people had >10x lower risk of hospitalization or death from #COVID19 compared with those not fully vaccinated. The best way to protect yourself & those around you is to #SleeveUp. More: https://t.co/7GBRXOApe7. pic.twitter.com/Te4CyBJZsy
— CDC (@CDCgov) September 10, 2021
The USPSTF maintains the recommendation to screen for chlamydia and gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.
15 Sep, 2021 | 08:57h | UTCEditorial: Screening for Chlamydia and Gonorrhea – JAMA
Evidence Report : Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Author Interview: USPSTF Recommendation: Screening for Chlamydia and Gonorrhea
JAMA Patient Page: Screening for Chlamydia and Gonorrhea
Report: Fully vaccinated people account for 1.2% of England’s Covid-19 deaths.
14 Sep, 2021 | 10:07h | UTCFully vaccinated people account for 1.2% of England’s Covid-19 deaths – The Guardian
Original Report: Deaths involving COVID-19 by vaccination status, England: deaths occurring between 2 January and 2 July 2021 – Office for National Statistics
COVID-19 vaccine efficacy does not support boosters for general population, review concludes.
14 Sep, 2021 | 10:08h | UTCNews release: COVID-19 vaccine efficacy does not support boosters for general population, review concludes – The Lancet
Original article: Considerations in boosting COVID-19 vaccine immune responses – The Lancet
Commentaries:
FDA experts among group opposing US booster shot plan – Associated Press
FDA vaccine regulators argue against Covid-19 vaccine boosters in new international review – STAT
Global experts pan wider use of COVID vaccine booster dose – CIDRAP
Boosters Are ‘Not Appropriate’ – Reach Unvaccinated First – Health Policy Watch
Data Doesn’t Support Need for COVID-19 Vaccine Boosters: Experts – HealthDay
Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors.
14 Sep, 2021 | 10:05h | UTCCovid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors – BBC
See also: Covid-19: Children aged 12-15 should be offered vaccine, say UK’s chief medical officers – The BMJ
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021.
14 Sep, 2021 | 08:57h | UTC
M-A: Study shows significant risk of major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism.
14 Sep, 2021 | 08:55h | UTCLong-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Long-term Anticoagulation After Unprovoked VTE: New Insights – TCTMD
Extended Anticoagulation Tied to Major Bleeding Risk – HealthDay
Commentary on Twitter
🆕 Delighted to share the MAJESTIC Study providing best available estimates for major bleeding risk during extended #anticoagulation of up to 5 years in patients with unprovoked #VTE (& clinically important subgroups), now published in @AnnalsofIM!https://t.co/Ri2EvZvffq pic.twitter.com/3jvN8mTKSi
— Faizan Khan, PhD (@FaizanK91) September 13, 2021
‘Do not resuscitate’ decision recorded for only 1 in 5 very sick hospitalized older patients, study finds
14 Sep, 2021 | 08:40h | UTCOriginal study: Do not attempt cardiopulmonary resuscitation (DNACPR) decisions for older medical inpatients: a cohort study – BMJ Supportive & Palliative Care
Four factors that increase the risk of vaccinated people getting COVID.
12 Sep, 2021 | 22:02h | UTCFour factors that increase the risk of vaccinated people getting COVID – The Conversation
What’s the evidence for COVID-19 booster shots?
12 Sep, 2021 | 22:05h | UTCWhat’s the evidence for COVID-19 booster shots? – Canadian Medical Association Journal
Risk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions.
12 Sep, 2021 | 22:03h | UTCRisk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions – CNN
Original study: Hospitalisation among vaccine breakthrough COVID-19 infections – The Lancet Infectious Diseases
News release: Study examines severe breakthrough cases of COVID-19 – YaleNews
Commentary on Twitter
New Comment: Hospitalisation among vaccine breakthrough #COVID19 infections https://t.co/1MtOoO8HVV, by Prerak V Juthani, @hyungjchun, and colleagues pic.twitter.com/mYAAEzHLDL
— The Lancet Infectious Diseases (@TheLancetInfDis) September 8, 2021
Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.
12 Sep, 2021 | 21:54h | UTCCommentary: Outcome Good at One Year for Majority of PIMS-TS Patients – HealthDay
Commentary on Twitter
A new study reports that a small number of pediatric patients are at risk for poor long-term outcomes of multisystem inflammatory syndrome in children. https://t.co/rUk4YEGRin pic.twitter.com/CgBi33Mzd5
— JAMA Pediatrics (@JAMAPediatrics) September 2, 2021


